Edgewise Therapeutics Inc [EWTX] stock prices are up 18.36% to $32.69 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EWTX shares have gain 8.10% over the last week, with a monthly amount drifted -0.55%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Edgewise Therapeutics Inc [NASDAQ: EWTX] stock has seen the most recent analyst activity on November 22, 2024, when Evercore ISI initiated its Outperform rating and assigned the stock a price target of $45. Previously, Piper Sandler started tracking the stock with Overweight rating on March 07, 2024, and set its price target to $48. On May 01, 2023, Truist initiated with a Buy rating. Goldman downgraded its rating to a Sell but stick to its price target of $5 on August 25, 2022. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $31 as its price target on April 13, 2022. Goldman started tracking with a Neutral rating for this stock on January 28, 2022, and assigned it a price target of $11.
The stock price of Edgewise Therapeutics Inc [EWTX] has been fluctuating between $6.82 and $38.12 over the past year. Currently, Wall Street analysts expect the stock to reach $46.25 within the next 12 months. Edgewise Therapeutics Inc [NASDAQ: EWTX] shares were valued at $32.69 at the most recent close of the market. An investor can expect a potential return of 41.48% based on the average EWTX price forecast.
Analyzing the EWTX fundamentals
Gross Profit Margin for this corporation currently stands at 0.29% with Operating Profit Margin at -65.34%, Pretax Profit Margin comes in at -55.19%, and Net Profit Margin reading is -55.19%. To continue investigating profitability, this company’s Return on Assets is posted at -0.24, Equity is -0.27 and Total Capital is -0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.63 points at the first support level, and at 24.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 36.13, and for the 2nd resistance point, it is at 39.56.
Ratios To Look Out For
It’s worth pointing out that Edgewise Therapeutics Inc [NASDAQ:EWTX]’s Current Ratio is 26.35. As well, the Quick Ratio is 26.35, while the Cash Ratio is 2.36.
Transactions by insiders
Recent insider trading involved Russell Alan J, Chief Scientific Officer, that happened on Sep 20 ’24 when 75000.0 shares were sold. General Counsel, MOORE JOHN R completed a deal on Sep 20 ’24 to sell 50000.0 shares. Meanwhile, General Counsel MOORE JOHN R sold 20922.0 shares on Sep 23 ’24.
